ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000604.1|GE2270_1 # 1 # 714 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.654	BGC0000604.1|GE2270_1 	1	714	+	Loose	420	48.9062	adeN	36.21	3000559	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGGCGCGGCGACGCGACGTCGAACGGGTGGATCGGATCGTTGACGCGGCAGCGGAACTGCTGCCTGAGCGGGGATATCGGCGACTGACGGTCGAGGAGGTCGCAAGCCGGGCGGGCGTCTCCAAAAGCAGCGTCTACCTGCACTGGAACACCAAGGACGAAATCTTCTACGCCGTGCTGGACCGCGAGTTCACCGTGCTGGCGCAGGCGGCCGTGGACCGGGTCAGGCGCGATCCAGCCGAGGTGCTGGCGCACCGGACGGCGGCCAACCTCTTCCAGATCGTCGCCTGCCGGCCACTGCTACAGGCGTTACTCGTCGACGACCGGACAACGCTCGGATCGCTGCAACCCGCGAAATCTGCTGTTTTCCGGGCCAGCCTCGCGAATCTCAACGAACTGATGTATCGCTATCTTCACGCGCTACGCATAAACGGACTTCTCTGCCCCGAGGTCGACCCGCGTATTATGCGGAAAGCGATTTCTGAAATGCTGCGCGGAATGACGTTCTCCGCGGGCGCGAAACCGTTGGCCGAGACACGGCTGGCCAAGTTGTCCCAGGTCGTCGCGGTGACCGTGCAGCGCGCCTTCGAACCGGGCGACGTGCCCGAACTCGACCGGATCAACGCCGCCGCGGCGGAGGTGTTCAAGGCGTTCGACGAGCTCATGCCGGCCGAGGAGACGATGCGCGCCGAACGCCCGGTGGCGCTGTGA	VTARRRDVERVDRIVDAAAELLPERGYRRLTVEEVASRAGVSKSSVYLHWNTKDEIFYAVLDREFTVLAQAAVDRVRRDPAEVLAHRTAANLFQIVACRPLLQALLVDDRTTLGSLQPAKSAVFRASLANLNELMYRYLHALRINGLLCPEVDPRIMRKAISEMLRGMTFSAGAKPLAETRLAKLSQVVAVTVQRAFEPGDVPELDRINAAAAEVFKAFDELMPAEETMRAERPVAL	MHDPVLESHHLVCEKPQTRRGIERRLALLLSATELFLEKGYDAVSLDDIVNHAGGSKTSIYKYFGNKDGLFTAICDYRREMFFKDICIAFQPEQTSLKDYLIQTLIRFYKPFIQPEHIAFLRLVIEQTQCNATLSQYLYEKCALDVQNTIAQALLISHQSGEITCTSPDHSSLMYFGILRDIEWRMIMGMPLPPNETEVIDYINYCVDIFLKGHHKV	109.22	gnl|BL_ORD_ID|1737|hsp_num:0	1880			54	228	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000604.1|GE2270_2 # 711 # 2612 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=CGA;rbs_spacer=15bp;gc_cont=0.756	BGC0000604.1|GE2270_2 	711	2612	+	Loose	800	28.1054	ParS	30.67	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	GTGACCGTGGTGCGCGCGCACGTCCGCCAGGAGCCGGCCGCGCTCGTCGTCGGTCGCGGCCTGCTCGCCGACCGGCTCGCGGCGGTGACCGGCCGGCTAGACCCCGGAGTGGTGCTCGCGGTGTCGGACGCGCCGGACCCCGCCGTGCTCGCGGAGGCCAGGGCGACGGGCCGGCCCGTGCTGCCCGTGCTCGCCGAGCCGGGCCGGGTACGGGTCGGGCCGCTGGAACGGCCGGGCGAGCCGGGCTGCTCCGACTGCCTGAGCCTGCGCAGGCACCGCGCCGCCAGCCGGTCGGCCGAACGGGCCGCCGCCTGGCTCCGGCACGGCCCGGACCTGGCCGCCACGCCCTCGCCGCTGCTCGCGCCGGTGGCGCTCGACCTGGTGGCCGAGCTGGTCACCGCGCTGGTCACCGCCCCCGCGCCGGCCCACCGTGGCATCCTGCTGGCCGACCTGTCCGACCTGAGCGTGACACCGCACGCCTTCCTGCCCGATCCGTTCTGCCCGCGCTGCGGCACCCTGCCCGACGACGACCCGGCGCGGGCGCGGATCACGCTCGTGCCGCGCCCGAAACCGTCGCCGGACCGGCACCGGGTGTGGGACGCCGAAGGCCGGCTCGACCGGCTCAGGCAGATCTACGTCGACGACCACTGCGGCCTGGTCCACTCGCTCAACCCGGCCGCGCTGGGCTCGCTCGCCGTCGCCGGTGCGCCGATCCGGCTGCGCGGCACCACCGCCTTCGAACCCGGATTCGGCCGCTCCCGCAGCTACCGCCGGAGCTCCGTCATCGCGCTGCTCGAAGCCCTGGAACGGTACGGCGCGATCGGTCCCGGTGGCAGGCGCGGCACCGTGCGCGCCAGCTACGCCTCCCTCGGGAACCTGGCGGTGGATCCCAGGTCGCTGGGGTTGCACCCGCCCGAGCACTACGCGCTGCCGGGCTTCCCCTACCGGCCGTTCACCCCGGAAGCGGTGTGCCGCTGGCTGTGGGGGCACTCGTTCGCCACCGGCGGCCCGGTGCTGGTGCCCGAGCGCAACGTCCACTACGGCCCGTCCGACGACGATCGGCCGTTCTGCTACGAGCTCGCCAATGGCTGCGCTCTCGGCTCGTGCCTGGAGGAGGCCGTCTTCCACGGCATTCTGGAGGTGCTGGAACGCGACGCGTTCCTGCTGACCTGGTACACCCGCGCCCGCGCGCCGCGGCTCGACCTCGGCACCGCCCGCGACCCCACGATCCCGCTGGTCGCCGCCGCGATCACGGCGGAGACCGGCTATCTCGTCGAGTGCTACGACATCACGCCCGACCACGGGGTGCCCTGCGTGTGGGCGCTGGCCCGCCATCCTTCCGACGGCGAGCCGGCCACGATCAGCGCCGCGGCGGCCGGCCCCGGCCTGGAACCCGCCGCCGCCGGCGCGCTGGCCGAGCTCGGACCGATGGTGCCGACCGTGCGCGACCACTTCCCACAGCACGCCGGCCGGGCGCGGGAGCTGGCCGCGGACGGCCGGCGGGTGCGATCCATGATCGACCACTATCTCGTGTACGGCGTGCGGTCGGCGGCACGCCGCTTGTCGTTCCTCACCGACGGCACGGAGGAGGTGCCCTTCGCGCCCGCACCGGACGGCTTCCGGCACGACGACCTCACCGCCGACCTGAGGTTCCTCCTCGACCGGCTGGCGGACAGCGGGCTCGACGTGGTCGTGGTGGACCTGACCACGCCGGAGCACCGCGCGGGCGGGCTTCGCTGCGTGAAGGTGCTGGTGCCCGGTACGGTGCCGATGACGTTCGGCGAGCAGAACCGCCGCACGTGGGGCCTGCCGAGGCTGCTCGACCCGGCCGTGGTGCGGGGGCGCGGCATGCCGGTACGCGGCCACGCTGATCTGAACCCCGACCCCCACCCCTTCCCGTGA	MTVVRAHVRQEPAALVVGRGLLADRLAAVTGRLDPGVVLAVSDAPDPAVLAEARATGRPVLPVLAEPGRVRVGPLERPGEPGCSDCLSLRRHRAASRSAERAAAWLRHGPDLAATPSPLLAPVALDLVAELVTALVTAPAPAHRGILLADLSDLSVTPHAFLPDPFCPRCGTLPDDDPARARITLVPRPKPSPDRHRVWDAEGRLDRLRQIYVDDHCGLVHSLNPAALGSLAVAGAPIRLRGTTAFEPGFGRSRSYRRSSVIALLEALERYGAIGPGGRRGTVRASYASLGNLAVDPRSLGLHPPEHYALPGFPYRPFTPEAVCRWLWGHSFATGGPVLVPERNVHYGPSDDDRPFCYELANGCALGSCLEEAVFHGILEVLERDAFLLTWYTRARAPRLDLGTARDPTIPLVAAAITAETGYLVECYDITPDHGVPCVWALARHPSDGEPATISAAAAGPGLEPAAAGALAELGPMVPTVRDHFPQHAGRARELAADGRRVRSMIDHYLVYGVRSAARRLSFLTDGTEEVPFAPAPDGFRHDDLTADLRFLLDRLADSGLDVVVVDLTTPEHRAGGLRCVKVLVPGTVPMTFGEQNRRTWGLPRLLDPAVVRGRGMPVRGHADLNPDPHPFP	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	147.90	gnl|BL_ORD_ID|2790|hsp_num:0	3805			561	762	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000604.1|GE2270_3 # 2609 # 5098 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=CGA;rbs_spacer=15bp;gc_cont=0.773	BGC0000604.1|GE2270_3 	2609	5098	+	Loose	1900	29.6462	AcrF	25.33	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCCGCCACGCGCCGCCCGCCGTCGCCCGGGTGGGCGGGCTGCCGGCCGCCGCGCTGCACGGGGTGGCCTGCCCCGAGGCGACCCGGCTCGCCGGCCGCGTGGTCCACCTCACCGAGGAGCTGACCCGACGCGCCGCGGTGCTGTCCGACGCTCTCTACGAGGTGATCGGCGCCGCCGGCGCGCACAAGCCGATCCTGGTGGCGATCCGCCGCGACCTGCACGGGCTGCGCCGGCCCAAACGCGTCGAGGTGCTGCCCGCGCCGTTGGCCGAGCCGGTCCGGACGTGGATCTCGCTGTGGGAAGAGCGCGCCCGCGTCCACGCCGTGCTGCCGGACGTGCTCGCCCGCGAGGAGCGCTTGGCCTGGGAGGCGCTGCGGGAGCTCGCCGCGACCCCGGCGGTGCGGCACGGGCTCGCGCACGCCAGCCCGGACCTCTCCGCCGACCTGGAGAAATGGCTCGCCGATACGGGGTGGCGGCCGCGACCGAGCACGCTGGCGAGCCTGCTGCGGTACGTGAAGCGCGTGGCGGCCAAGACGAGCCCCTTCAGCACGTTCACCACCGTCCACGAGGTCCGCTGGGTGGACGGCGGCGCGGCCTGGCAGGTGCCGGACACGGCGCCGACCGTGGTGGTGGAGGCCGACGTGGGGCTCCGGCTGCTGGTCGAGTCCGTGCTGCCGCGCATGCCCGAGGTGGCCGCCGCGCGGGTGGTGCGGCTGTCGCCGGCCGCGTACGCGTCGGGGGACCGGCTGGCGTTCCCGGAACCGGGCGGGCGGATGCGCGCGGTGGACCGGACCTCCGCACTGGACACCCTGGTCGAGCTGCTGCGCGCCGAGCAGCGGTGGGACGCGGCGATCGCCAAGCTCACCGGTGCCGGCCTGGCAGGCCACGGAGCAGAGGACGGTACGCGTGACAGCGCGAGCGACGGAACGGCGGCGGCCGAGCAGGTGCTGAGCGGGCTGGTGCGCGGCGGGCTGGTGGAGGCCGTCGTGCCGGTGCCCGGCCAGGCGGCCCGTCCGTTCGCGCGCCTCGCCGACTGGGCGGCGCCCGCTGCGCCCGCCGGCCCGCTGCACCGTATCCAGGTGGCCTTGGACCAGGCCGGGCCGCTCGGCGACGGCGACCCGTTGGCGTCGGCCTGCGCCCACGTGGCCCGCCGCCTCACCGCCGAACTCCCCGCCCTGGGCCTGCCCGTCATGCCGGTGCCCGACCTGCGCCGTCGTGTGCTGCGCGAGTCGGCGCTCGGCGCGCCGGTCGCCTGCGCGCTGCGGGAGTGGCGACCCGTGCTGGCCGACCTCCAACGGGTCCGCCGCTGGCTCGCCGTGCACGACCCGATGCTGCCGCTTCGCCTCACCCTGGCCGACCGGGTACGCGACTGGTTCGGCCCCGGCTCGGCCGCGCCCCTGCTGGACGTGTACGCCAGGGTCCGGACCGCCGAACCGGGCACGCCCCTGGATCCCGACTTCCTCGAACACCCCGACCCGCTCGCCGGCGTCACCGACCCGCGCCTGACCCGCCTGCGCGAGCTGCGCGCCGCGTCGGTCGCCGCGCTCACCGGGGGGCGGGCGGAGGAGGCGCTGAGTGAGCCGCCGGCCTGGGTACGCGATCCGGGGCCGGTCACCTGCTATGTCCAGCCGTTCCAGGGGGAGGACGGCCTGCGGCTGGTCCTCAACGCCGCCCACGGCGGTCACGGCCGGGGCATCACCCGCTGGACCAGGCTGCTGGGCGCCGAGCCGCCGCCCGGCGAGCCCCCGGCTGCCGAGTCCCCGCCCGGTGAGTCCCCGCCCGGTGAGCTCCCGCCCGGTGCGTGCCTGGTCGCCGAGCTGCCGGGCACGTTCGGCCACAGCCTCAACCTGCACGCGCCCGCCACCGGCTGGGAGCTGACCTACCCGGGCGCGGTGAACCAGGCCCCGCCGGAGCGCCGCGTCCCGCTGGCCGAGCTCCAGGTCCGGCACGACGCCGGGCGAGGCGTCGTCGAGCTGTGGTGGCCGCGCGCCGGCCGGCGCGTCGTGCCGGTGCACGCCGGCATGATGTCGGAGACGCTGCTGCCGCCCCTGGCCCGCCTGCTCGTCGAGGCGTTCGGCACCACCCACCTCACCCATCCGACCCTGCCGCCCGTGGTGCGGGCCGCCGGTCCGCGCATCGACCTGGGCCGCGTCACGCTCGCCAGGGCCCAGTGGACGGCCCGCCGCGAGGAGATTCCGCGGCGGGGCGGCGACGACGCCGCCCACCTCGTCGCCGTCCACGCCTGGCTGCGCGCCGCCGGGATCCCGCGCCGCTGCTTCGTCCGCGTCCGCGAACCGCAGGTGCGGAGGGACCGGCTCGCCTTCGACAAGCGGCACAAGCCGGTGTTCGTCGACTTCGGGAGCTGGCCGTCGGTGCTGGAGTTCGACCGGATCGTCACCCGGGCCACCGGGGACCTGGAACTGACCGAGGCACTGCCCGACGGCGAGCGGGCGGTGGAGCTGGCGATCGAGATAGGAGCCCGGTGA	MSRHAPPAVARVGGLPAAALHGVACPEATRLAGRVVHLTEELTRRAAVLSDALYEVIGAAGAHKPILVAIRRDLHGLRRPKRVEVLPAPLAEPVRTWISLWEERARVHAVLPDVLAREERLAWEALRELAATPAVRHGLAHASPDLSADLEKWLADTGWRPRPSTLASLLRYVKRVAAKTSPFSTFTTVHEVRWVDGGAAWQVPDTAPTVVVEADVGLRLLVESVLPRMPEVAAARVVRLSPAAYASGDRLAFPEPGGRMRAVDRTSALDTLVELLRAEQRWDAAIAKLTGAGLAGHGAEDGTRDSASDGTAAAEQVLSGLVRGGLVEAVVPVPGQAARPFARLADWAAPAAPAGPLHRIQVALDQAGPLGDGDPLASACAHVARRLTAELPALGLPVMPVPDLRRRVLRESALGAPVACALREWRPVLADLQRVRRWLAVHDPMLPLRLTLADRVRDWFGPGSAAPLLDVYARVRTAEPGTPLDPDFLEHPDPLAGVTDPRLTRLRELRAASVAALTGGRAEEALSEPPAWVRDPGPVTCYVQPFQGEDGLRLVLNAAHGGHGRGITRWTRLLGAEPPPGEPPAAESPPGESPPGELPPGACLVAELPGTFGHSLNLHAPATGWELTYPGAVNQAPPERRVPLAELQVRHDAGRGVVELWWPRAGRRVVPVHAGMMSETLLPPLARLLVEAFGTTHLTHPTLPPVVRAAGPRIDLGRVTLARAQWTARREEIPRRGGDDAAHLVAVHAWLRAAGIPRRCFVRVREPQVRRDRLAFDKRHKPVFVDFGSWPSVLEFDRIVTRATGDLELTEALPDGERAVELAIEIGAR	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	80.17	gnl|BL_ORD_ID|1353|hsp_num:0	1437			2040	2433	ciprofloxacin
BGC0000604.1|GE2270_4 # 5095 # 6129 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.766	BGC0000604.1|GE2270_4 	5095	6129	+	Loose	880	26.1794	arlS	34.69	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACGCGGTACCCGCTGCCCCGCCCCCACCCCCTCGGCATCCACCCCGGCTACGCCCGGCTGCGCGAGGGCTGCCCCGTCGCGCGGGTCGACTCGCCGTACGGTCCGGCCTGGCTGATCACCCGGTACGCCGATGTGGCGGCGGTACTCACCGACGCCCGGTACAGCCGCGCGGCGGCGACGGAGGACGACGGCGGCATCCTGCTCAACACCGACCCGCCCGAGCACGACCGGCTGCGCAGGCTCGTGGTGGCGCACACCGGCGCCGCCGCCGTCGAGCGGCTCCGGCCGCGGGCCGAGGAGATCGCCACCACCCTGGCGAAACGCATCCCGGCGGAGGCCGAGTTCGTAAGCGCGTTCGCCGAGCCGTACTCACATCGGGTGCTCGCGCTGTTCGTCGGGCACCTGGTCGGCCTGCCGGCCGGCGAGCTGAGCCCGATGGCCACCGTGCTCACGCTGGCGCGGGTGCCCGACCGGGAGCGGGCGGCGGCGTTCGCCGAACTGCGCCGGCGGCTGCGGAGCCAGGTGGACGACGAGACGCTCGCCGTGGTGCTCAACATCGTCTTCGGCGGCCACGCGGCGGTGGTGGCCGCGCTGGGCTACTGCCTGCTCGCGGCGCTGGCCGAGCCGCTGCCGAGCCTGACCGGCGATGTCCGGCGGATCGCCGAGCTGGTCGAGGAGACGCTGCGCCTGGCTCCGCCCGGCGACCGGACCCTGCTGCGCCGCACCCTCGAGCCCGTCGAGCTGGGCGGGCGGGAGCTGCCCGCGGGAGCGCTGGTGATCCCGTCGATCGCGGCGGCCGGCCGGGATCCGGACCGGCCCACCGGCGGGCCGGCGGGCCGGCACCTGGCGTTCGGCCGCGGCCCGCACGCGTGCCTCGGCATGGCGCTGGCCCGGATGGAGCTCCGGGTCGCGCTCCAGGCGCTGGCCGAGCACGTCCCCGGACTGCGGCCGGCGGTCAGCCCGGCCACGCTCAGGCGTACGTGCGAGGAATTGGCGGTCAGCCCGCTTGCGGGAATCCCGATTCGGGTGTAG	MTRYPLPRPHPLGIHPGYARLREGCPVARVDSPYGPAWLITRYADVAAVLTDARYSRAAATEDDGGILLNTDPPEHDRLRRLVVAHTGAAAVERLRPRAEEIATTLAKRIPAEAEFVSAFAEPYSHRVLALFVGHLVGLPAGELSPMATVLTLARVPDRERAAAFAELRRRLRSQVDDETLAVVLNIVFGGHAAVVAALGYCLLAALAEPLPSLTGDVRRIAELVEETLRLAPPGDRTLLRRTLEPVELGGRELPAGALVIPSIAAAGRDPDRPTGGPAGRHLAFGRGPHACLGMALARMELRVALQALAEHVPGLRPAVSPATLRRTCEELAVSPLAGIPIRV	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	76.27	gnl|BL_ORD_ID|165|hsp_num:0	182			747	891	ciprofloxacin; acriflavine; norfloxacin
BGC0000604.1|GE2270_5 # 6095 # 6274 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.556	BGC0000604.1|GE2270_5 	6095	6274	-	Loose	700	21.1718	ACT-87	35.71	3006279	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGGTGTTCTGCGGACACGATTCTCCCTCGGTTTCTCACACCGAATGCGTGCACCATTTCTGGAACCGAGAGTATGACCCGGGCGTGATCCGCGGCAAGGAATGGGCACCCGCTGACCAAATTCGTTTATTCGGTTTTCTGCCCACTACACCCGAATCGGGATTCCCGCAAGCGGGCTGA	MVFCGHDSPSVSHTECVHHFWNREYDPGVIRGKEWAPADQIRLFGFLPTTPESGFPQAG	MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGISMLDLATYTAGGLPLQVPDEVTDNASLLRFYQYWQPQWKPGATRLYANASIGLFGALAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDTEAYGVKTNIQDMASWLKANMNPDALSDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLANKSYPNPARVEAAYRILSALQ	15.49	gnl|BL_ORD_ID|3137|hsp_num:0	4175			462	579	
BGC0000604.1|GE2270_6 # 6482 # 6904 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000604.1|GE2270_6 	6482	6904	+	Loose	700	27.335	ACT-53	28.85	3006248	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGATTGAACTGTGTGAGATCGGTGCGGATCCGCAGCCTCCTGCTGGGCCCAACATCTCATTCCGCATATCTTCCGACGGCGGGGTGACGGCCATCGCCAATCGCGGTGAGATCGCCAAGAAGGTGCAGCCCAACCCCTTTCACGCCGGCTCCGCCGCCGCGTCGCCGGGCGGCCGGCTGCGCATCTATCCCGGCTACGCCACCAGCGAACTGTCGGCCCGCCTCGGTGAGCGCTACCTGTCCACGTTCTACCAGCGCACCCTGCTCAAGCGCGTCGTGCTCGACCCGGGCACCGTGGTCGAGGACGCCGACGCCGGTGAGGGCATCACCGTCAACCGGTCACAGTACCGAGGCGTCGGGTTCGAACTGCACACCAGGGCCGACGGCGCGGACCGCGAGATCGTCGCCGCGCTCGTGCGCTGA	MIELCEIGADPQPPAGPNISFRISSDGGVTAIANRGEIAKKVQPNPFHAGSAAASPGGRLRIYPGYATSELSARLGERYLSTFYQRTLLKRVVLDPGTVVEDADAGEGITVNRSQYRGVGFELHTRADGADREIVAALVR	MMTKTLCCALLLSTSCSALAGPLSEKQLAEVVEQTVTPLMKAQAIPGMAVAVIYEGQPHYFTFGKADVAKNKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQWQGIRMLDLATYTAGGLPLQVPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVQPSGMSYEQAITTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPEALQDTSLGQGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVEAAYRILDALQ	36.75	gnl|BL_ORD_ID|3106|hsp_num:0	4144			786	942	
BGC0000604.1|GE2270_7 # 6947 # 8065 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0000604.1|GE2270_7 	6947	8065	+	Loose	450	25.7942	rmtH	40.0	3003198	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCTGAGCAGCGCGCTCGAAGTAGACATCGACGAGGCGGCCGTCGCCGCCGACCTCAGGGAACTGGCCGCGGCGCTCGACCGCAGCGGCTACGGCGAGATCCTGACGTGCTTCCTGCCGCACAAGGCGCAGGCGCACATCTGGGCGCAGACCGCCGCGAAGATCGACGGTCCGCTACGGACACTGATGGAGCTCTTCCTGCTCGGCCGGGCAGTGCCGCAGGACGACCTGCCGGCCCGGGTCGGCGACCTCATCCCCGGGCTCGCCGCCACGGGCCTGGTGCAGACCGGGCAGGGCGCGGTGTGGCTGCCCAACCTTATCCTGCTGCGGCCGATGGGCCAGTGGCTGTGGTGTCAGCGCCCGCACCCGTCGCCCACGATGTACTTCGGCGACGACTCGCTCGCGCTGGTGCACCGCATGGTGACCCATCGCGGCGGCCACACCCTCGACCTGTGCGCGGGGCCGGGCGTGCAGGCGCTGACCGCCTCGCTGCGCAGCGACCGCGTCACCGCCGTCGAGATCAACCCCGTCGCCGCCGCGCTGTGCCGCACCAACATCGCCATGAACGGCCTGGGCGACCGGATGGAGGTCCGCCTCGGCGACCTCTACGGCGCGGTGCCGGGCGAGGTCTTCGACGACATCGTGTCCAACCCGCCGCTGCTGCCGGTGCCCGAGGACGTCCAGTTCGCCTTCGTCGGCGACGGTGGCCGCGACGGCTTCGACATCTCCTGGACCATCCTCGACGGCCTGCCCGAACACCTGTCCGATCGCGGTGCGTGCCGGATCGTCGGCTGCGTGCTCAGCGACGGCTACGTGCCCGTCGTGATGGACGGGCTCGGCAAGTGGGCCGTCGAACACGACTTCGACGTGCTGCTCACCGTCACGGCGCACGTAGAGGCGCACCGCGACTCGTCGTTCCTGCGCAGCATGTCGCTGATGTCCAGCGCGATCTCGGGCGAGCCGGCCGACGTCCTGCAGGAGCGCTACGCCGCCGACTACGCCGAGCTGGGCGGCTCCCACGTGGCCTTCTACGAGCTGTGCGCGCGGCGCGGCGGCGGCACGGCACGGCTCGCCGACGTCTCGGCGACCAAGCGCTCCGCCGAGGTCTGGTTCGTCTGA	MLSSALEVDIDEAAVAADLRELAAALDRSGYGEILTCFLPHKAQAHIWAQTAAKIDGPLRTLMELFLLGRAVPQDDLPARVGDLIPGLAATGLVQTGQGAVWLPNLILLRPMGQWLWCQRPHPSPTMYFGDDSLALVHRMVTHRGGHTLDLCAGPGVQALTASLRSDRVTAVEINPVAAALCRTNIAMNGLGDRMEVRLGDLYGAVPGEVFDDIVSNPPLLPVPEDVQFAFVGDGGRDGFDISWTILDGLPEHLSDRGACRIVGCVLSDGYVPVVMDGLGKWAVEHDFDVLLTVTAHVEAHRDSSFLRSMSLMSSAISGEPADVLQERYAADYAELGGSHVAFYELCARRGGGTARLADVSATKRSAEVWFV	MTIEQAAADILSSKKYQLLCPDTVVRILTQEWGRHKKPKQAVERTRERLHGICGAYLAPQVEKQASTALAAGDVQKALALHASTRERLDTYPQLYQFVFENNLPARVLDIACGLNPLMLHRQGVASVWGCDIHQGLGNVLTPYAQKHGWDFTFALHDVLCAPVAASGDMALVFKLLPLLEREQPGAALALLRTLDAPVICVSFPTRSLGGRGKGMHQHYATWFEGLVAPHFTVQHHTLIGDELLYRIQPNPA	147.62	gnl|BL_ORD_ID|33|hsp_num:0	41			279	384	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000604.1|GE2270_8 # 8094 # 9338 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=6bp;gc_cont=0.704	BGC0000604.1|GE2270_8 	8094	9338	+	Loose	750	26.9498	tet(55)	29.17	3004591	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCCGACCACACTCCCGAAGACCCTGCGCGGGTCGGACGGCGCGCTCGCCGAGCAGCCGCTGCTCATCTACGTGAATGTGCCGTTCTGCAACTCAAAATGTCACTTCTGCGACTGGGTGACCGAGGTTCCGCTGGCGGATCTGCGGCTCACGCCGGACTCGTCGCCACGCCGCCGCTACGTCGCCGCGCTGGTCAAGCAGATCGAGACGCACGCGCCGACGCTGGGCGGACTCGGCTACCGGCCCGAGGTCATGTACTGGGGCGGCGGCACGGCCAGCATCCTCACCATCGAGGAGATCGAGGCGGTGGCTGGGGCGCTGGCGGCGCGGTTCGACCTCGGCGGCCTGGTCGAGGCCACCATCGAGGGCAGCCCGGAGTCCATGGACCCCGGCAAGCTGAAGCTGTTCCGTGCGATCGGGTTCAACCGGATCAGCATCGGGGTGCAGGCGTTCGACGACGCGCGCCTGCGCCGCATCGGCCGGGTGCACAGCGCCGAGCAGGCGGAGCGCGCGGTCCGGATGGCCGCCGACGCCGGCTTCGACAACATCAACATCGACCTCATCGTCGGGTTCCCCGGGCAGGGCGCCGACGAGGTGTCGCGCACGATCCAGCACGCGGTGACGCTGCCGGTCAACCACTTCTCGGTCTACCCCTACCGGCCGACCGGCGGCACCGTGATGCGCCGGCAGGTGGGCCGCGGCATGGGCCGGATCGACGTGGAGGAGCAGCTCCGGTCGTACGACCACGCCCGCGACCTGCTCGCCCGGCACGGGTTCGAGGAGTACGCCACCGCCTACTTCGGCGCTCCCCGCTGCGAGTCCGACGAGGTCTACTACAAGCTCACGATGGACTGGATCGGGTTCGGCTCCGGGGCCAACTCCCTCATCGGGACCCGCTTCCTGCTGAACGACCGGGGCGGGCTGCACCGCTTCAGCACGGCCCCGCACCGCTTCGACTCCGACACCCCGGCCTCGGCCCCCCACCTGACACGCCACTTCCTGGCCCAGGCGCTGACCACGGTCGACGGCATGGACGCGCGCACCTTCCAGCTGCGCACCGGCCGTTCGCTGCGGGCGGCGTGCGAGGAGCCCGCGGTGCGCCGGATGCTCGAACAGATCAACCGCCGCGGCAGGCTGATCGTCGACTCACGCGGCATCCGGCTGCACCGCGACGACATGGCCTCGGCCTACATCACCATGAACAGCGTCGATCTGTACGCCGCGACCGAGCAGCCCGGCGGATGA	MPTTLPKTLRGSDGALAEQPLLIYVNVPFCNSKCHFCDWVTEVPLADLRLTPDSSPRRRYVAALVKQIETHAPTLGGLGYRPEVMYWGGGTASILTIEEIEAVAGALAARFDLGGLVEATIEGSPESMDPGKLKLFRAIGFNRISIGVQAFDDARLRRIGRVHSAEQAERAVRMAADAGFDNINIDLIVGFPGQGADEVSRTIQHAVTLPVNHFSVYPYRPTGGTVMRRQVGRGMGRIDVEEQLRSYDHARDLLARHGFEEYATAYFGAPRCESDEVYYKLTMDWIGFGSGANSLIGTRFLLNDRGGLHRFSTAPHRFDSDTPASAPHLTRHFLAQALTTVDGMDARTFQLRTGRSLRAACEEPAVRRMLEQINRRGRLIVDSRGIRLHRDDMASAYITMNSVDLYAATEQPGG	MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY	107.53	gnl|BL_ORD_ID|2727|hsp_num:0	3293			1002	1146	tetracycline; minocycline; oxytetracycline
BGC0000604.1|GE2270_9 # 9372 # 9635 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.652	BGC0000604.1|GE2270_9 	9372	9635	+	Loose	400	23.0978	VIM-69	31.03	3005517	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	GTGAACCCGTGTGCCCTTCCCACGTGGGGACGGGCGTGCCGGTCGACCGCCGCGGGCTCGCGAAGGAATGAGGGTCACAACGGAAAGGAGATGAGCGAGTTGGAATCCAAGCTGAACCTTAGCGACCTGCCCATGGACGTCTTCGAGATGGCCGACAGCGGCATGGAGGTCGAATCCCTCACCGCAGGCCACGGGATGCCCGAGGTAGGCGCTTCCTGCAACTGCGTGTGCGGCTTCTGCTGCTCCTGCAGCCCGTCCGCGTAG	MNPCALPTWGRACRSTAAGSRRNEGHNGKEMSELESKLNLSDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA	MFQFRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTAALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYASPLTRQLAEAAGNEVPTHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGNVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTDVVKTHKVRPVAE	32.83	gnl|BL_ORD_ID|4647|hsp_num:0	5718			639	726	
BGC0000604.1|GE2270_10 # 9697 # 12129 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=15bp;gc_cont=0.769	BGC0000604.1|GE2270_10 	9697	12129	+	Loose	500	27.7202	CRH-3	48.48	3006867	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CRH beta-lactamase	ATGGAGGTGGGCCGCGAAATCGTGGTCCGCGTGGCGGGGCTGCCCGCCGCCGTGCTCGCCGACCTGCGCCTGCCGCACACCGCCGAGCTCGTCACGCACCTGTCCGCTGAGCGGCGGCGGCTCGCCGCCGAGGCGGCTGCGCTGTCCGGCGAGCTGTTCGACCTGATCGGCGCCGCCGGCTCCGCCCGCGCCGCCCTGGTGGGCCTGCGGCGCGCGCTCGCCCCCGGGCACCGCCCCCCGTCGCCGCGACTGATCGGGCTGTGTCCCCTGCCCGCCCCGCTGGCCGAGCGGGTCACCGCCTGGGTGCGGGCCCGGTACGACTGGGAGGACCGGCGCCGCGACCTTGCCGGCACGCTGGACAAGGAGCGCGCCGACGCGCTCGACCGCGTACGCGCCGCCTGCGTCGCCCCGGCGTTCCGGCGGGGTCTGGCGCTGTCCGGTGGGGAGCTGACCAGCACGCTGGAGCGCTGGCTCGCCGACCCCGGCCGTGCGCCCCGGCAGGGGAAGGTGCTCCGCCTGGTCAAGTACCTGACCCGAGCTGCGGCCAAGACCAGCCCGTACGGCTCCTTCATGGTCAGCGCGCTGGCGGGGCGGCCCGGCGACGACCCTCCCATCCCGGAGCTGCTCACCGTGGCCGAGCCGCCGGGGGCGTTCCTCGACGCCGTCGGCGACGCGCTGCTCGCCGACCCGGCACTGGCCGGCCAGGTGCCGCTGCGCCCCAACCCCAGCCTGACGTGGACCGCCCAAGGACTGCTTTTCGTCCGGACCGTCCGCGCGGCGGCGGGAGAGCAGGCCGGGCCGAAGGAAGAGATCGCCACCGCCGGGCGCGCCGCCGCGCTGGAGCTGTGCCTGCGGCACGCCGAGTCCCGGCCCACCGCGCCGCAGCTGGCGGAGCTGCTGGCCGAGGCGGGGGCGGATCCGGGCGAGGCGGCCGCGTTCGTCGACCGGCTGGTGGCGGCGCAGCTCCTGCTGCCGTGTCCGCCGGTGCACGACGACGATCCCGACCCGTTCGGTGCCTGGGCCCGCCAGGTGTGCGCCCCGGAGCTGCGCGAGCTGGCGGCCGCGTCGCGGCCCGTGGCCGCCGCCGTGGACTCGCCCGGCCAGCGCCGCGCCAGGATCGCCGAAGCCGCCGCCGCCGTGGCGGACCGGCTCGGCATCGACCCGCCCGCCGATCCGGCGCACGAGCACGACGTCAGCACCGGCCGTCCGGCGCCGCCACCGCTGCCCGCGGGCGTGCTCGCCGACCTGGACGCGGTCCGGCGCTGGCTCGCCGTGTTCGACTGGAAGGTGCCCGTCCGGGTGGGGGTCGGCGCGTTCTGCCGCGAACGTTTCGGCTCAGGGTCCCGCACGCCCTTCCTGGAGGCGTGCCGGGCGGCGACGGCGGCGCTGCCGCACCTGTTCGGCCCCGCCGCGATGCCGTGGTTCCTCGACCTGACCGGTGACGGTCGCCTGCGTGAGCTGGACCGTCTCCGGACGCGCGCCCGCGATCTCGCCCGCTCCGGCGTCCTCGACCGGCGGCGGGTGCTGGCTGACACGGCCGACTGGCCCGCCTGGCTGACCTGGCCCGCCTCCACTGGTTTCTACCTGCAGACCCTGCCCGGTGGGGTGGTGCTGAACGCGGTGCATGCCGGGCACGGCCGCGCGGCGGGTCGCGTCCACCACCTCCTCGCCCGGGCGGGCGCCGCGCCGCCGCGCCCGCCCCGCTCCGGCCTGCCGCGTGCCGAGTTCGGCGGCAGGTTCGGCTCCGCGCTCAACACCCGCACGCCGAGCACGCGGTACGAGATCGACCACCCCGGCGCGACGTCCGGCCGCGACCCCCGGCACCGTGTCCCGCTCGGCACGCTCATGGTGGTGCACGACCCGGACACCGACCTGGTCCACCTGCACAGCGACCGGCTCGGCCGCGTCGAACCGGTGCACCTCGGCATGATGGGCGAGCTGGGGCTGCCCGCCGTGGCCGGTTTCCTCGAACGCGCCTTCGCGCCCACCTACCTGTTCCACCCGAGCGTGCCGCCGTTCATCTCGCTGCGTGACCTGGCCGGCGCCTCCTCGGCGCGGCGCTTCCCCAGGGTGAGTGTCGGCGACGTGGTCGTGCAGCGCGCCCGCTGGACGGTGCCCGCCGGCCTGGTGCCCGCGCGTACCGGGGCGGACGGTGACCACCTGCTCGCGCTGGCCGAGTGGCGGCGCGAGCACGGCATCCCCGAGCGGTGTTTCGTGCGCGGCTGGAAGCCGGGCGCAGCGCTGGGCAAGGCGCGCAAGCCGCTCTACGTCGACTTCGCCTCCTGGCATCTGGTCGCCCTGTTCGAACGGGAGGCGCGAACCAACGCCGCCCTGGTCATCGACGAGGCCCTGCCGGACCCGCTGGCCGACGGCGCCCCCGCGCACGTCACCGAGTACCACGTCGAGATCGGCGACCGGGAGAGAGAGCAATGA	MEVGREIVVRVAGLPAAVLADLRLPHTAELVTHLSAERRRLAAEAAALSGELFDLIGAAGSARAALVGLRRALAPGHRPPSPRLIGLCPLPAPLAERVTAWVRARYDWEDRRRDLAGTLDKERADALDRVRAACVAPAFRRGLALSGGELTSTLERWLADPGRAPRQGKVLRLVKYLTRAAAKTSPYGSFMVSALAGRPGDDPPIPELLTVAEPPGAFLDAVGDALLADPALAGQVPLRPNPSLTWTAQGLLFVRTVRAAAGEQAGPKEEIATAGRAAALELCLRHAESRPTAPQLAELLAEAGADPGEAAAFVDRLVAAQLLLPCPPVHDDDPDPFGAWARQVCAPELRELAAASRPVAAAVDSPGQRRARIAEAAAAVADRLGIDPPADPAHEHDVSTGRPAPPPLPAGVLADLDAVRRWLAVFDWKVPVRVGVGAFCRERFGSGSRTPFLEACRAATAALPHLFGPAAMPWFLDLTGDGRLRELDRLRTRARDLARSGVLDRRRVLADTADWPAWLTWPASTGFYLQTLPGGVVLNAVHAGHGRAAGRVHHLLARAGAAPPRPPRSGLPRAEFGGRFGSALNTRTPSTRYEIDHPGATSGRDPRHRVPLGTLMVVHDPDTDLVHLHSDRLGRVEPVHLGMMGELGLPAVAGFLERAFAPTYLFHPSVPPFISLRDLAGASSARRFPRVSVGDVVVQRARWTVPAGLVPARTGADGDHLLALAEWRREHGIPERCFVRGWKPGAALGKARKPLYVDFASWHLVALFEREARTNAALVIDEALPDPLADGAPAHVTEYHVEIGDREREQ	MFKHLILLASITAPLTQAVAADPLSVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPNERFPLCSSFKGFLAAGVLAQSQDKPGLLDKRIRYSKTALPNWSPITTKHQASGMTVAELNAASVQYSDNGAANLLLKEINGPAALTAFMRSIGDARFRLDRLEPELNSAIPGDPRDTSTPKAVAESAQKLALGKALPEPQRQRLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGTANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK	279.31	gnl|BL_ORD_ID|3414|hsp_num:0	4483			390	486	
BGC0000604.1|GE2270_11 # 12126 # 13025 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.758	BGC0000604.1|GE2270_11 	12126	13025	+	Loose	750	28.8758	PAC-1	26.32	3005150	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	PAC beta-lactamase	ATGACCGAACGGCCCGGCTGGTTCGCGGCGCATGTGCACTACCGCGGCGACCTCGACGCGCTGCTGCGCGAAGCGGTCGCGCCGCTGGTGCGCGCGCTTGCCGCCGACTTCTTCTTCCTGCGCTACTGGGACGGGGGCAGCCACCTGCGGCTGCGGCTGCGCGGCGGGGACCAGGTCGCGGTCGCCCGGCACCTGGACGCCTACCTTGCCGCCCACCCCGCGCCGGAGACCACCTCCCAGGAGGAGTACGCCCGCGTCGCCCCGGTGCTGGCCGCCCGCGAGGGCATGACGGGCCACCTGACGACGCTGCGGCCGAACAACACCGTGGAGTTCGCGGCGTACCGGCCGGAGACCGCGAAGTACGGCACCGGCGACGCGCTACGCGCCGTCGAGCGGCATTTCGTCGAGTCCAGCCGGTACGCGCTTGACGTCCTTGACCGCCGCCCGACCGGCAACCAACGCGAGCTCGCAGTGCTCGGCGTCCTGCTGCTCGCCTGGTACGCCGCCCGCCCACTCGATGAGCCGCCTGGTGAGCCGGTCGATGACGAGCTGATCGGCGCGGTCGAGGCGCTGTGCCGGGGCTGGCGCGGCGGCCGGGACCTGCCCGAGGAGCTCGTGGCGGAGGAGTACGGCCGGGTGCGGGAGCGTGTGGCCGGGCTGGCCGGCGCGCTGCGTGACCTCGTTCCGGACCCGGACGCGCCCGGCAGCAGCATGCGCGCGTGGGCGGCGACGTTCGACCGGCTCGCCGCCGCGCTGCCCCCGCCCGACCGGCTGCGGGTGCTCGACACGTGCGCGCATCTGGCGGCCAACCGGCTGGGCGTGTCCATGGCGGCCGAGGTGCGGCTGCGGCTGCTCGCCGCGCGGGCCCTGCGCGAGGTCGCGCCCGTGGGGAGGCGATGA	MTERPGWFAAHVHYRGDLDALLREAVAPLVRALAADFFFLRYWDGGSHLRLRLRGGDQVAVARHLDAYLAAHPAPETTSQEEYARVAPVLAAREGMTGHLTTLRPNNTVEFAAYRPETAKYGTGDALRAVERHFVESSRYALDVLDRRPTGNQRELAVLGVLLLAWYAARPLDEPPGEPVDDELIGAVEALCRGWRGGRDLPEELVAEEYGRVRERVAGLAGALRDLVPDPDAPGSSMRAWAATFDRLAAALPPPDRLRVLDTCAHLAANRLGVSMAAEVRLRLLAARALREVAPVGRR	MRCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFYNYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAFDRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLITAQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAYGLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKETLLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANKWYPNDARIEAAYELVQRLKK	78.48	gnl|BL_ORD_ID|2857|hsp_num:0	3875			483	792	
BGC0000604.1|GE2270_12 # 13022 # 14026 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.749	BGC0000604.1|GE2270_12 	13022	14026	+	Loose	875	26.5646	tet(O/M/O)	34.48	3007120	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGATGAGCTGGCGACGCGTCGACGTGGCCTACCACGATCCCGACCTTGACGGGCTGATCCTGGCCACCCGGCCGCTGCTGGCCGGGACGCCCGGCCGCGGCTGGTTCCAGCGGCACTGGGTCCGCGGTCCGCACCTGGAGCTGTGGTTCGACGCCGCGCAGCCGTCGTGGGAGCGGATCCGCGACGTGCTGGAGCCCTGGCTGCGCGTCAACCCGTCGCGCGCCCGGATCGACCGAGACCGGCTGCTGGCGCAGCACCGGCACCTCGCCGCCGCCGAACGGATCGACGAGCCGCTGCTGCCGTTCTACGCCGACAACACGCTGCACCGGGCCGCTCCGCGCTCCCGCGCACACGTGCTCGGTGGTCCGGCGGCCGAGGAGCTGTTCCACGACTTCCACACCACCGCCAGCGCCGTGGCTTACGACGAGCTCGACGCCGTGCGGGCGGGAGAGTCGCGGCTGGTGATGGCACTGGACCTGATGGTCGCCGCCGCGCACGCGCACGCCGAGGGCGGCGTCCGCGGCGGGTTCGTGTCGTTCCGCTCGCACGCGGAGGCGTTCCTGGCGAGCGCGCCCGGCCTGCGCGAGCGCTGGGACGCCGAGTACGCCGCCCGGGCGGGGGCGCTGCGAGCGCGGATCACCGCGGTGGTCGCCGGAATCCCGCGCGGCCGGGCGTGGGCCGGGCTGCTCGACCGGTTCGCGGACCGCGGCGACGAGCTGATCGCCTCCGGCGCGCTGCTGGTCGAGCCCGCCGGGCCGGACGCGGTCGCCCGGCCCGACACCGCCTTCCACCGGGCGCTGCGCGGCAACCGGACCTGGCACGAGGAGGTGCTGCGCTCAGCACCGTTCCGCCGCTACCGGCTGCTGCTGAACCTGACCTACCTGCAGCTTTCCCGGCTCGGGGTGAACGCCGTGCAGCGGGCGCTGCTGTGCCACTTCGCCGCGTCGGCGGTCGAGCAGGAGTACGGGGTGTCCGCCATCGAGATCGCCATGGGAGGCGCGTGA	MMSWRRVDVAYHDPDLDGLILATRPLLAGTPGRGWFQRHWVRGPHLELWFDAAQPSWERIRDVLEPWLRVNPSRARIDRDRLLAQHRHLAAAERIDEPLLPFYADNTLHRAAPRSRAHVLGGPAAEELFHDFHTTASAVAYDELDAVRAGESRLVMALDLMVAAAHAHAEGGVRGGFVSFRSHAEAFLASAPGLRERWDAEYAARAGALRARITAVVAGIPRGRAWAGLLDRFADRGDELIASGALLVEPAGPDAVARPDTAFHRALRGNRTWHEEVLRSAPFRRYRLLLNLTYLQLSRLGVNAVQRALLCHFAASAVEQEYGVSAIEIAMGGA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPMLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	52.27	gnl|BL_ORD_ID|4794|hsp_num:0	5790			999	1155	tetracycline
BGC0000604.1|GE2270_13 # 14113 # 15390 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.753	BGC0000604.1|GE2270_13 	14113	15390	+	Loose	700	26.5646	CMY-78	60.0	3002091	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGCTCGCCGCCTGGCCGCACGCCACGCCGCTCGGCCGGGCCACCCCCGAGCTGCTGGCCCTGCTGGACGGCCTGGCCGCCGGATCGCTGCCGCTCGACGAGCCCGGCGACCTCGCGCCCGCCGTCGAGCTGCTGCGCGCGGGTGGCTGGCTGCGCAAGACGGTGGCGTACGCGGGACGCGACCTCTACACCATCACCCCCGTCGCCGCCCCCACCGACGCGCCGCCACCGCCGCGGGACGAACCGGCGCTGTCGCGGTTCGCGCTGCTGCGCAACACCGCGGACGGGCTGGTGCTGGAGATGCCCGGCTCCTGGTGCGACGTCCACGTGCACGACCCGGCGGTGGCCGCGCTGCTCGCCGACCCGTCCGGCGACGGCGGCCTGCCCGCCGAGGCCGCGGCCGCGCTGCGCGCCGACCTGGCCGCCGCCGGCATGCTGATGGAGCGGGAGGAGCCGTTCGAGCGGCGGCAGTGGAGCACCCACGAGCTGTGGTTCCATGAACGCAGCCGGCTCGGCAACCGGGGCTGGTTCGGCGCGCACTTCGGCGGCACGTTCTGGGCCCGCGGCCGGCACGACCCGCCGCCCGCGCGGCCGTCCCCCTACCCCGGCCCGGCCGTCGAGCTGGCCCGGCCGGACCTCGCGGCGCTGCGGCGCACCGACCCCACGCTCACCGCCGTGCTGGAGGACCGCGAAAGCGTCCGCGACCACGACGACGACGATCCGATCAGCGCTGAGCAGCTCGGCGAGCTGCTCTACCGGTGCGCGCGGGTGCGGCTGCTGCGTCACCTGGAAGGCTTCGAGTACGCCGGCAAGCCGTACCCCGCCGGTGGCTCGGCGTACGAGCTAGAGGTGTACCCGGTCGTGCGGCTGGCCCGCGGCCTCGACCCCGGCATGTACCACTACGACGCGCACGACCATCGGCTGCGCCAGGTCCGGCCCGCCGGCCACCCGGCGGTGCGCAGGATGCTGAAGGTCGCCACGGAGTCGTCCGTCGCCAAGGCGCCGCCCCAGGTGCTGCTGGTGATCAGCGCGAGAGTCGGCCGGATCCTGTGGAAGTACGAGGCGATGGGGTACGCGCTCATGCTGAAGCACGTCGGCGTGCTGCAACAGACGCTGTACGCGGTCGCCACCGCCATGGACCTGGCCCCGTGCGCGCTCGGCAGCGGGGACGATCTCGCCTTCACCGCCGCCACCGGCCGGGACCGGCTGGTGGAGTGCGCGGTCGGCGAGTTCATGGTCGGCAGCAGGCGGAAGGAGCCCGCGGCATGGGAGCTCTGA	MLAAWPHATPLGRATPELLALLDGLAAGSLPLDEPGDLAPAVELLRAGGWLRKTVAYAGRDLYTITPVAAPTDAPPPPRDEPALSRFALLRNTADGLVLEMPGSWCDVHVHDPAVAALLADPSGDGGLPAEAAAALRADLAAAGMLMEREEPFERRQWSTHELWFHERSRLGNRGWFGAHFGGTFWARGRHDPPPARPSPYPGPAVELARPDLAALRRTDPTLTAVLEDRESVRDHDDDDPISAEQLGELLYRCARVRLLRHLEGFEYAGKPYPAGGSAYELEVYPVVRLARGLDPGMYHYDAHDHRLRQVRPAGHPAVRRMLKVATESSVAKAPPQVLLVISARVGRILWKYEAMGYALMLKHVGVLQQTLYAVATAMDLAPCALGSGDDLAFTAATGRDRLVECAVGEFMVGSRRKEPAAWEL	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	111.55	gnl|BL_ORD_ID|1505|hsp_num:0	1634			399	459	
BGC0000604.1|GE2270_14 # 15378 # 17204 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.773	BGC0000604.1|GE2270_14 	15378	17204	+	Loose	275	29.6462	AAC(6')-IIc	30.09	3002596	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGGAGCTCTGAACCTCCTCCTGCGCCCCGACGCGCACTACGCCGAGGTCGACGGCGGCGTCTACGTGCTGAGCCACCAGGGCGAGACCTTCATCTCGGGCACCTCGGTGCACCGGTGGCTCGACCGCCTCGCGCCGCTGCTCGACGGCACCCGCACGCTCGACCAGCTCACCGCCGGCCTGCCCGCCGACCGGGCCGGCTTCGTGGCCAGACTTGTCGGCACGCTCACCGAACGCGGCCTGGTGCGCGAGGTCGGCCCGGCGGTGTCGGACACGCTCACCGACGCCGAACGCGGCGAGCACCGTGCCCTGCTGGCCTACCTGGGCTACTTCCACGACTCGCCCGGCCGCGTCCTCGAGGACGTGCGCGACACCCCGACCGCGATCGTGGGGTCCGGTCCGCTGGCCGCCGCGGTGGTCCGCGCCTGCGCCGCCGCCGGGCTGCGCCGGGTGGAGATCGGCGAGGAGGCGGGCGCGGCCCGGGTGGTCGTCCACGTGGCCGAGCGCGCCGAGCCCGAACGGGCGGCGCGGCTGGAACGGCGGTGCGCCGCCGAGGGGGTGCTGCTCGCACAGGTCATGCCGGGGCCGGACGGCATCTGGTGGCAGCCCGCGGCCCGCGGCGGCTGCTGGGCGAGCGCGTGGCGCCGCCACCGGGCGCTCGCGGGCGTGGATCGGACGGGCACGCCGCTCGATCCGGTGGCGGTCGCGGTGGTGGCCGGCCAGGTGGCACACGACGTCTTCCGCGTCCTCGCCGGACTGCGCGAGGAGGCGCCGCCCCGGTTGGTGGTGCTCGATCCGCGGACGCTGGCGAGCACCGCGCACCCGGTGGTGGCGCACCCGTTCGAGCTGCCCGCCGCGCCGCTGGACGAGGCGGCGTTCCTCGACCGGGTCGCCGCGCTGCGGGCAGCGCCCGCGCTGAGCGAGGCGGAGTTCTCCCGGCGGGCCAAGGGGCTCATGGACTCGACAGTGGGGCTGTTCGCCGAGATCGACGAGGGCGACCTCGCGCAGTTGCCGCTGCACGTCACGGCGACCACGGTGGCCGACCCGTGCGGGCTGATCGGCTCCGCGCCGCGGCCCGTGGTCACCGGCGCGGGGCTCACGTTCGAGGAGGCCCGCTACCGCGCGGCGCGCGCCGCGCTCGCCCTGGCCGGCACTCTCGCGCTCGACCGGCGGAGGCTGGTCGACGGCCGGGTGTGGGCGTACGACCTTGCGGACGGGGCCGCCCGGCTGGTTCCGGCCGACGAGGTCTTCGCAAGCACGGCGGGCGGGAGCACGGCGGGCGTGCCGCTCGGCGCGGCGGCAGCCTACTCGTGGGCCGAGGCGGTCGCGGAGGGCCTGGTCGCGCAGGCCGCCGCGCTCACTCTCGCCGGCGCCGGGCACGCGGGCGAGCCGTATGGACGGGCGGACCTCGCCGGGGCGCCTGCGTATCTCCTCGCCATGGTGCGGGCGCTCGGCGAGGAGCTGACCGTGCACGACGTCACCGGGCCGCTGGGCGTGCCGGTCGTGGTGGGGACGCTGTCCGGCGGGGCGACCGCCTGCGGCGCGGGCATGACCACGGACGCCGCCGTCACCGCGTGCCTGCGCGACCTGCTGCTGCTGCGCCAGGCCGAGATCAACGACCAGCCCGTCTACGCCCCACCATCCGGCAGGCCCTTGCCCGGGCATCTACGCGGGAACCACCCGGCGCCCGCCGTGCCCGGCACGGACGCCGACCGGCTGGCGGCCCGCCTGGCCGAGCGGGGGCACCGCCCTCTGGCGGTGCCGCTGGATCATGACCAGGCCGTGCACGCGGTCCTGCCCTTCGCCGTCCGGGTGGTGTGCCGATGA	MGALNLLLRPDAHYAEVDGGVYVLSHQGETFISGTSVHRWLDRLAPLLDGTRTLDQLTAGLPADRAGFVARLVGTLTERGLVREVGPAVSDTLTDAERGEHRALLAYLGYFHDSPGRVLEDVRDTPTAIVGSGPLAAAVVRACAAAGLRRVEIGEEAGAARVVVHVAERAEPERAARLERRCAAEGVLLAQVMPGPDGIWWQPAARGGCWASAWRRHRALAGVDRTGTPLDPVAVAVVAGQVAHDVFRVLAGLREEAPPRLVVLDPRTLASTAHPVVAHPFELPAAPLDEAAFLDRVAALRAAPALSEAEFSRRAKGLMDSTVGLFAEIDEGDLAQLPLHVTATTVADPCGLIGSAPRPVVTGAGLTFEEARYRAARAALALAGTLALDRRRLVDGRVWAYDLADGAARLVPADEVFASTAGGSTAGVPLGAAAAYSWAEAVAEGLVAQAAALTLAGAGHAGEPYGRADLAGAPAYLLAMVRALGEELTVHDVTGPLGVPVVVGTLSGGATACGAGMTTDAAVTACLRDLLLLRQAEINDQPVYAPPSGRPLPGHLRGNHPAPAVPGTDADRLAARLAERGHRPLAVPLDHDQAVHAVLPFAVRVVCR	MSANNAAIVLRVMAENDLPMLHAWLNRPHIVEWWGGEDERPTLDEVLEHYSPEVLAKQAVVPYIAMLDDEPIGYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLNKGLGTKLVRSLVELLFSDPAVTKIQTDPSPSNHRAIRCYEKAGFVQEKNILTPDGPAVYMVQTRQAFESLRTVQSFKIKGKWS	315.03	gnl|BL_ORD_ID|674|hsp_num:0	730			261	552	dibekacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000604.1|GE2270_16 # 18969 # 19337 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000604.1|GE2270_16 	18969	19337	+	Loose	2070	23.483	smeE	25.0	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTACGTGGTGATCGTCGCGTTCGACCTGAAGGAGTCCTCCGTCGACTTCGCCGAACTGCGCGCCTGGGTGCGGGACCGGGCGGCGGACGACTACTCCCGGCTGCCGGGGATGCGCTTCAAGACGTGGTTCTCCGACGAGCGAAAACGGCTCTGGGGCGCGGTGTACCTGGTGGAGTCGATGTTGTCGTTCGACCGGGACAACCTCCCGCTGCTGCCCGACGGCAGGACCGGGCCGGTCGGCACCCGGCCGACGTCGGTCATGGTGCTGGAGTTGGAGGCGTTCGTCACCGGGCCGGACGGCCTGGACGGGATCGAGGCGCTCGCCCGGCAAGGGCTGAGCATGACGGGAGGCGGCCATGACCACTGA	MYVVIVAFDLKESSVDFAELRAWVRDRAADDYSRLPGMRFKTWFSDERKRLWGAVYLVESMLSFDRDNLPLLPDGRTGPVGTRPTSVMVLELEAFVTGPDGLDGIEALARQGLSMTGGGHDH	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	11.73	gnl|BL_ORD_ID|807|hsp_num:0	876			417	561	tetracycline; chloramphenicol
BGC0000604.1|GE2270_17 # 19327 # 20577 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.709	BGC0000604.1|GE2270_17 	19327	20577	+	Loose	1320	26.9498	lmrD	26.51	3002882	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACCACTGAGGCGACGACTGCGGTGACCACTCGTGCGAACGCCGGAGCGCTGTCCCTGCCGGCGCGTGGCACGGACCGGCCGCTGCTGCTCTACGTCAACATCCCGTTCTGCAACTCCAAATGCCACTTCTGCGACTGGGTGGTGGACGTGCCCGTCTCCGACCTGCGGCTCGCCCCCGCGGCGCCGCGCCGGGTCGACTACCTGGCCGCGCTGTGCACCCAGATCCGCACGCACGCCCCCGCCTTGCGGGCCGCCGGTTACCGCGGTGAGGTCATGTACTGGGGCGGCGGCACCGCCACCGTCCTCACCGCGGCGGAGATCGAGCAGGTCCACGCCTGCCTCGCGGCCGAGTTCGACCTGACGGCGCTGGCCGAGGCGACGATCGAGGGCAGCCCCGAGTCGGTGGACCCGGCCAAGCTGAGGCTGCTGCGGGACCTCGGCTTCGACCGGGTGAGTCTCGGCGTGCAGTCGTTCGACGAGACCAGGCTGCGCCGCATCGGCCGCGCCCACTCCGCGGGCCAGGCCGTGCGCAGCGTCGAGGACGCGCACGCGGCGGGCTTCGACAACATCAACATCGACCTGATCGTGGGCTTCCCCGACCAGTCGCTCGCCGAGGTGGAGCAGACCGTGCGGCGCGCCCTCGACCTGCCGGTCAACCACTTCTCGGTTTACTCCTACCGAGCGACCGAGGGCACGGTGATGCGCAGGCAGATCGAACGCAGCGGCACGGCCATCGAGCTGGAGCATCAGCTCCAGTCGTACCGGCTGGCGGGCGAGATGCTCGCGGCGGCGGGACATCCCGAGTACGCCGTCTCCTACTTCGGTGCGCCGCGCTGCCTCGCCGACGAGGCGTACTACCGGCTCAGCATGGACTGGATCGGCTTCGGCACGGGCGCCAACTCGCTGATCAACCAGCGCTACCTGCTCAACGGCCGCGGCCGGATGCGTGACTTCACCAGCAGGCCGGGCGAGTTCGAGGTGGACCTGCCGGCCGGAGTGCCGTCACTCACCGTGCAGTGGCTGCCCAGGGCGCTGGGCACCGCCGAGGGCATCGACGCGGCGACCTTCCAGCGTCGCACCGGCACGTCCCTGCGTGCGGCCTGCGAGGAACCCGAGCTGAACGCGTTCCTCACCCGGGTGAACGAGTTCGGCCGGCTCGTCGTGGACCGCGACGGCATCCGCCTGGCCGACGAGAACCGCTCGGACGTGCTGTCGCGCACGTTCGCCGCGATGGGCTGGGTGTCCTGA	MTTEATTAVTTRANAGALSLPARGTDRPLLLYVNIPFCNSKCHFCDWVVDVPVSDLRLAPAAPRRVDYLAALCTQIRTHAPALRAAGYRGEVMYWGGGTATVLTAAEIEQVHACLAAEFDLTALAEATIEGSPESVDPAKLRLLRDLGFDRVSLGVQSFDETRLRRIGRAHSAGQAVRSVEDAHAAGFDNINIDLIVGFPDQSLAEVEQTVRRALDLPVNHFSVYSYRATEGTVMRRQIERSGTAIELEHQLQSYRLAGEMLAAAGHPEYAVSYFGAPRCLADEAYYRLSMDWIGFGTGANSLINQRYLLNGRGRMRDFTSRPGEFEVDLPAGVPSLTVQWLPRALGTAEGIDAATFQRRTGTSLRAACEEPELNAFLTRVNEFGRLVVDRDGIRLADENRSDVLSRTFAAMGWVS	MENTKSTRKMSDTTRAIRFFYLYLKRYKLQFAVIMIFIILATWLQVVSPSLLGDAITNLTKYVTDFFTHQHAGQSQDALQQIAQQLSQQMHQTVDWHNVPEVVKSLPQAAQDQITANLPKGTTLETLKTVATSHAASTSTFMKGMWQLLAVYVATGVSMLIYTLLFSRIVAHSTNRMRKGLFGKLERLTISYFDRHQDGDILARFTSDLDNIQNTLNQALVSVISNAAVFVGVIIQIFNKDVTFAWLTVAASPVAILSAVIIIRQSKKATDKQQEEVSQLNAYMDEKISGQKAIIVEGLQEDSINGFLEHNENVKKRTFAAQAWSGMIFPLMNGFQLLSIAIVIFGGTAYVLNDDSMSIATGLGLLVAFVQYVQSYYNPIMQISSNFGQLQLAITGATRLNVMFDEPEEVRPENGKKFDTIKDGIQIENLDFEYLPGKPVLKKVNIDVKKGQMVALVGPTGSGKTTVMNLMNRFYDVNGGAIKFDGTDIREFDLDSLRSNVGIVLQESVLFDGTIADNIKFGKPNATQEEIETVAKTTHIHDFIDSLPDKYETHVSDDESVFSVGQKQQISIARTILTNPELLILDEATSNVDTVTEQQIQWAMEAAIAGRTSFVIAHRLKTILNADKIVVLKDGEVIEEGNHHELVAQGGFYSELYHNQFVFE	62.65	gnl|BL_ORD_ID|1488|hsp_num:0	1624			723	972	
BGC0000604.1|GE2270_18 # 20579 # 21598 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=9bp;gc_cont=0.763	BGC0000604.1|GE2270_18 	20579	21598	+	Loose	600	28.1054	LMB-1	38.24	3005018	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	LMB beta-lactamase	GTGGAGGCGATGCGCACGCTGCTCGCGGCCGCCGACCTGGTCACGCCGATGGCGCTGCGGGTGTCGGCGACGCTGCGGCTCGCCGACCACCTGGCCGCCGGCACGACCGGCGCCGCCGAGCTCGCCGCGGCCGCCGGGGTCGACGAGGCGGCGTTGACACGGCTGCTGCGCTACCTGGTCGCGCGCGGCGTCTTCACCGAGCCCGCGCCCGGTGAGTTCGGCCTCAACCCCGCCGCCGAACTGCTGCGCGACGGCCGCCCCGACCGGCTGCGCGACTGGCTCGACCTCACCGGGCCGATCGGCCGCGCCGACCTGGCGTTCGGGTCGCTGCTGGACGTCGTACGCACCGGCAAGCCCGGTTACCCGATGATCCACGGCCGGGGCTTCTGGGACGACCTCGCCGCCGAGCCGGCGCTCGCCACCGCGTACGACACCCTGATGGGCGGCAAGCGCCAGTGGGCCGCGACCACGCTCGCCGCCCTGGACTGGAGCCGCTCCCGGCACGTCGTGGATGTCGGCGGAGGCAACGGCACGCTGCTGTCGTGCCTGCTGGCCGCGCACCCGCACCTGCGCGGCACCGTCGTGGACCGGCCCACCTCCGCGAAGGCCGCCGGAGCAGTACTGGCCTCGGCCGGGGTGGCGGACCGTGGCGAGTTTCGCGCGGGCGACTTCTTCGAGCCGCTGCCGGTGCACGGCGCCGACACATACCTGCTCAGCTCGATCCTGCACGACTGGGACGACGCCGCGGCTACGGCGATCCTGCGCCGCTGCGCGGAGGCCGCCGCGCCGGGCGGGCGGGTGCTGCTCTGCGAGCTGGTGGCCATGGCCGGGCCGGACCGGCGGACGGTGACGCACATGGATCTGTGCATGCTCGTGTACTTCGGCGGCCGGGAGCGCACCGCCGCCGACTTCGCCGCGCTGGCCGGGGCGGCCGGGCTGGAGCCGCGCTCGGTGACGCCGCTCCCGCCCCACGACTGGGGCAACGCCCTCGTGGAGTACGCGGTCCCCGCCGCCCGCTGA	MEAMRTLLAAADLVTPMALRVSATLRLADHLAAGTTGAAELAAAAGVDEAALTRLLRYLVARGVFTEPAPGEFGLNPAAELLRDGRPDRLRDWLDLTGPIGRADLAFGSLLDVVRTGKPGYPMIHGRGFWDDLAAEPALATAYDTLMGGKRQWAATTLAALDWSRSRHVVDVGGGNGTLLSCLLAAHPHLRGTVVDRPTSAKAAGAVLASAGVADRGEFRAGDFFEPLPVHGADTYLLSSILHDWDDAAATAILRRCAEAAAPGGRVLLCELVAMAGPDRRTVTHMDLCMLVYFGGRERTAADFAALAGAAGLEPRSVTPLPPHDWGNALVEYAVPAAR	MTLAKSFRCFCLVTTLSSMAMLAGCGGTAPVTVLSPPPADWVNSCKDWDDWDKAGPPYRIYGNSYYVGTCGISAILITGDNGHILIDGATEAGAKVIAANIDRLGFSLRDVKLLLQSHEHFDHVAGLAQLQQQSGAKLLASPAAAPVLTSGVVAAADPQAGMHEPFPAVRVDGLVTAGQVVTLGKLSLLPVATPGHTPGALSWQWSSCEAGQCQVLVYADSLSPVSSDSYRFSEHLTYLNAYRASLHKLAALDCQILLTPHPSASNMRTRLQSSAGLTDTQGCVVYADAITQRLEQRLIKETTQ	111.51	gnl|BL_ORD_ID|2750|hsp_num:0	3761			42	144	
BGC0000604.1|GE2270_19 # 21934 # 22101 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=10bp;gc_cont=0.661	BGC0000604.1|GE2270_19 	21934	22101	+	Loose	1650	22.7126	Brucella suis mprF	41.18	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAGTTTCGTCCGCTTCTGTGAGGAACGCGGCGCTGACCGGGTGGCGGCGCGCCGGTTCGGCCTACATCAAGGAGCTGATGCCCGACATCTGGATGGCACCATCGAGCCGGGGCAAATGTTCGACGCCACGACCGATGCGATGTCCCGCGACCGGCCGTCGCGGTGA	MSFVRFCEERGADRVAARRFGLHQGADARHLDGTIEPGQMFDATTDAMSRDRPSR	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	6.25	gnl|BL_ORD_ID|2057|hsp_num:0	2281			2427	2529	defensin
BGC0000604.1|GE2270_20 # 22234 # 22848 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.662	BGC0000604.1|GE2270_20 	22234	22848	+	Loose	300	33.8834	dfrA35	23.53	3005164	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGCGAAGGTCATCTCTACGTTGTTCATCTCTGCTGACGGTGTGGCCGAGATCGACCCCGATTGGCACTTCCCGTACTTCGACGAGAACATGGGCCGCGCCGTCGGCGAGGACTATGACACCGCTGACGTGCTGTTGATCGGTCGCGAGACCTTCGACAGCTTCGCCGGAGCGTGGCCCGACCGCGAGGCGGCGGGTGGGGACGACGCACCGTTCGCCAAGCAACTCGGGGACATGCGCAAGGTGGTCGTCTCCCGCCAGCCGCTGGAGTTCTCCTGGCGCAACTGCGAACTGATCACGGGCGATCTCCTCGATGCCGTCACCTCGCTCAAGGCCGATGCCGGCATCAGGGGCATCCTCATCCCCGGTTCGATCTCCGTGGTGCAGCAGTTGCTCGCCGCAGGGCTGGTCGACGAGTTGCGCCTGCTGGTGCACCCGGTGGCGGCGCGTAAGGGCCGCAGGCTGTTCGACGACGGCGACGCGCCGTACCACCTGAGCGTGACGGCGACGGAGACGTTTCCGACGGGCGTGATCCGCGTGATCTACTCGCCGACCGAGGCACCCACCAAAGTCGGCTACGACGAGGTCGAGGCCCAGGTGTCCACCGGGGAATAG	MAKVISTLFISADGVAEIDPDWHFPYFDENMGRAVGEDYDTADVLLIGRETFDSFAGAWPDREAAGGDDAPFAKQLGDMRKVVVSRQPLEFSWRNCELITGDLLDAVTSLKADAGIRGILIPGSISVVQQLLAAGLVDELRLLVHPVAARKGRRLFDDGDAPYHLSVTATETFPTGVIRVIYSPTEAPTKVGYDEVEAQVSTGE	MISIVVAKSANHVIGVDNQLPWRLPSDLKWFKETTTGGVVVMGRKTFESIGKPLPDRINVIISKQPVPIEWASKVVWVNSIQQAMDYVRGLDGMIKTFIIGGSEIYRQFISLVDQVYLTEVGAEIEGDATFQPLDEHEWTLKTWWVVPDQSSKDQFRYQRKLYVRKVLDE	120.00	gnl|BL_ORD_ID|2871|hsp_num:0	3887			105	354	trimethoprim
